Close Menu

Caprotec Bioanalytics

New Products: Oct 8, 2010



The company said that protein targets binding specifically to the drug in question showed activity in pathways commensurate with the drug candidate's phenotypic profile.

The technology, which enables the isolation of functionally selected proteins from complex biological samples, has demonstrated potential usefulness in studying drug-protein interactions and could increase the efficiency of the drug development process.

Proceeds from the private financing will be used to further develop its Capture Compound Mass Spectrometry technology for analyzing complex protein mixtures.

New Products: Jan 29, 2010


Thermo Fisher Scientific, Caprotec Bioanalytics

Movers & Shakers: Nov 20, 2009


Christian Jurinke, Jeff Protentis, Jürgen Schumacher


The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.

According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic.

The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.

In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more.